Cancer Treatment News and Research

RSS

Physical comorbidity is associated with high psychological distress

Among patients with cancer, having additional physical comorbidities was linked with a higher risk of experiencing psychological distress. The finding comes from a Psycho-Oncology analysis of 2017 data from the National Health Survey of Spain.

18 Feb 2021

Researchers track how Osmium reacts in a single cancer cell

Osmium is a rare precious metal that could be used to treat cancer with fewer side effects when compared to Platinum, currently used in nearly half of chemotherapies.

17 Feb 2021

Mathematical model reveals how cell turnover determines the success of adaptive therapy

One of the most challenging issues in cancer therapy is the development of drug resistance and subsequent disease progression.

17 Feb 2021

Molecular imaging can predict response to novel metastatic breast cancer treatment

Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy.

17 Feb 2021

Changes to gut microbiome help melanoma patients respond to immunotherapy

Statistical modeling developed by Oregon State University researchers has confirmed that changes to melanoma patients' gut microbiome led them to respond to a type of treatment capable of providing long-term benefit.

16 Feb 2021

Researchers create new cancer optotheranostics based on photosynthetic bacteria

Cancer is one of the most thought-provoking healthcare problems throughout the world. The development of therapeutic agents with highly selective anti-cancer activities is increasingly attractive due to the lack of tumor selectivity of conventional treatments.

16 Feb 2021

Study: Targeted therapy prolongs survival in patients with advanced bladder cancer

In a new study led by researchers at Yale Cancer Center, the drug enfortumab vedotin (EV) significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma or bladder cancer, who had previously received platinum-based treatment and a PD-1–PD-L1 inhibitor.

15 Feb 2021

Scientists discover new immunotherapy target for malignant brain tumors

Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted the ground-breaking cancer treatment based on harnessing the body's immune system.

15 Feb 2021

Study investigates influence of adequate supply of vitamin D on prognosis of numerous diseases

In recent years, three meta-analyses of clinical studies have come to the conclusion that vitamin D supplementation was associated with a reduction in the mortality rate from cancer of around 13 percent.

11 Feb 2021

Scientists avert drug resistance in subtype of brain tumors

In far too many cases over the years, scientists have discovered promising new cancer treatments, only to report later that the tumor cells found ways to become resistant. These disappointing results have made overcoming drug resistance a major goal in cancer research.

11 Feb 2021

Researchers look at long-term outcomes of cancer patients diagnosed with COVID-19

Researchers at MUSC Hollings Cancer Center have joined a nationwide study to look at the long-term outcomes of cancer patients who have been diagnosed with COVID-19.

8 Feb 2021

Study shows efficacy of radionuclide therapy–immunotherapy combination in prostate cancer model

A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal of Nuclear Medicine.

8 Feb 2021

$FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma$

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.

5 Feb 2021

Scientists identify genomic signatures of long-term survival in luminal breast cancer patients

Researchers at NUI Galway have identified genomic signatures in women developing the most common type of breast cancer that can be associated with long-term survival.

4 Feb 2021

Novel 3D-printed esophageal stents could revolutionize the delivery of cancer treatment

World-first 3D printed esophageal stents developed by the University of South Australia could revolutionize the delivery of chemotherapy drugs to provide more accurate, effective and personalized treatment for patients with esophageal cancer.

3 Feb 2021

Intensity of physical training does not seem to matter during cancer treatment

People receiving treatment for cancer are known to feel better with physical training. But does it make any difference how vigorously they exercise?

3 Feb 2021

Reducing barriers in cancer care for LGBTQ2SPIA+ patients

In an upcoming issue of the Journal of Medical Imaging and Radiation Sciences, published by Elsevier, undergraduate researchers from the University of Alberta's Radiation Therapy Program in the Faculty of Medicine and Dentistry describe how LGBTQ2SPIA+ patients face unique cancer risks, including fear of discrimination, higher incidence of certain cancer sites, and lower screening rates, resulting in more cancers detected at later stages.

2 Feb 2021

Yale scientists develop an injection-based therapy for skin cancer

Yale researchers are developing a skin cancer treatment that involves injecting nanoparticles into the tumor, killing cancer cells with a two-pronged approach, as a potential alternative to surgery.

2 Feb 2021

Simvastatin is a promising drug candidate for treatment of ovarian clear cell carcinomas

Oncotarget recently published "Simvastatin is a potential candidate drug in ovarian clear cell carcinomas" which reported that based on previous studies, the authors assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G, and one high-grade serous ovarian cancer cell line, Caov3. The authors used the Rho GTPase interfering drug CID-1067700 as a control.

2 Feb 2021

Researchers discover novel metabolic gatekeeper mechanism for leukemia

In a new study led by Yale Cancer Center, researchers have discovered a novel metabolic gatekeeper mechanism for leukemia.

1 Feb 2021

Cancer Treatment News and Research

Physical comorbidity is associated with high psychological distress

Researchers track how Osmium reacts in a single cancer cell

Mathematical model reveals how cell turnover determines the success of adaptive therapy

Molecular imaging can predict response to novel metastatic breast cancer treatment

Changes to gut microbiome help melanoma patients respond to immunotherapy

Researchers create new cancer optotheranostics based on photosynthetic bacteria

Study: Targeted therapy prolongs survival in patients with advanced bladder cancer

Scientists discover new immunotherapy target for malignant brain tumors

Study investigates influence of adequate supply of vitamin D on prognosis of numerous diseases

Scientists avert drug resistance in subtype of brain tumors

Researchers look at long-term outcomes of cancer patients diagnosed with COVID-19

Study shows efficacy of radionuclide therapy–immunotherapy combination in prostate cancer model

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Scientists identify genomic signatures of long-term survival in luminal breast cancer patients

Novel 3D-printed esophageal stents could revolutionize the delivery of cancer treatment

Intensity of physical training does not seem to matter during cancer treatment

Reducing barriers in cancer care for LGBTQ2SPIA+ patients

Yale scientists develop an injection-based therapy for skin cancer

Simvastatin is a promising drug candidate for treatment of ovarian clear cell carcinomas

Researchers discover novel metabolic gatekeeper mechanism for leukemia

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News